MedPath

Exploration of Pregnant Women's Reluctance Toward COVID-19 Vaccination

Completed
Conditions
Vaccinate Against Covid-19
Reluctance Pregnant Women's
Registration Number
NCT06968117
Lead Sponsor
Centre Hospitalier de Gonesse
Brief Summary

This study aims to explore the reasons behind the reluctance of pregnant women to get vaccinated against COVID-19. With the ongoing pandemic, it has become essential to understand the concerns that women have regarding the COVID-19 vaccine, especially during pregnancy. Pregnant women are at a higher risk of severe complications from COVID-19, including premature birth, preeclampsia, and the need for intensive care.The goal of this research is to identify the barriers that prevent pregnant women from getting vaccinated, whether they are based on fears, misconceptions, or a lack of information. By understanding these concerns, healthcare providers can have better conversations with their patients and provide accurate, evidence-based information to help them make informed decisions about their health and the health of their unborn child.Through interviews and visual methods, the study seeks to gather valuable insights into the emotional and psychological aspects of vaccine hesitancy among pregnant women. These findings will help develop a tool to assist healthcare providers in addressing vaccine hesitancy effectively, ensuring that women are given all the necessary information to make the best decision for their health and the well-being of their baby.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
15
Inclusion Criteria
  • During pregnancy follow-up consultations,
  • Following their visit to the Gynecology-Obstetrics emergency department, regardless of the reason,
  • Hospitalized in the diabetology department or in the high-risk pregnancy (HRP) or postpartum care department.
Exclusion Criteria
  • The patient is over 18 years old

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The rate of vaccine hesitancy among pregnant women, assessed through a standardized questionnaire.January 2021-April 2023
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

France

🇫🇷

Gonesse, France

France
🇫🇷Gonesse, France

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.